CCL2 and inflammatory bowel disease: As such, CCR2 is a key component for the development of IBD, and the absence of the receptor or its cognate ligand CCL2, leads to reduced disease severity in mice models (Bain & Mowat, 2014; El Sayed et al., 2022; Pei et al., 2017).